Why the study?
Although oxidized CaMKII has been proposed to be important for early ischemia-reperfusion arrhythmias, direct evidence was lacking.
Population
Langendorff-perfused hearts and ventricular cardiomyocytes from C57BL/6 and MMVV mice
Comparison
Isoprenaline, KN93/AIP, NAC, and oxidation-resistant CaMKII (MMVV) vs controls
Design
Preclinical ex vivo and in vitro experimental study
Key result
Hearts from mice with CaMKII resistant to oxidation at methionines 281/282 (MMVV) had a similar incidence of early ischemia-reperfusion arrhythmias compared to wild type mice.
Authors
Loading...
Oxidation-resistant CaMKII yields similar early reperfusion arrhythmia rates in mice; leaves open alternative ROS-CaMKII mechanisms for targeted study.
Although CaMKII and ROS contribute to early ischemia-reperfusion arrhythmias, oxidation of CaMKII at methionines 281/282 is not a determining factor for these arrhythmias.
Hansen et al. (2022) studied Early ischemia-reperfusion arrhythmias. CaMKII resistant to oxidation of methionines 281 and 282 (MMVV mutation) vs. Wild type mice (WT) was evaluated on Incidence of early ischemia-reperfusion arrhythmias (IRA). Hearts from mice with CaMKII resistant to oxidation at methionines 281/282 (MMVV) had a similar incidence of early ischemia-reperfusion arrhythmias compared to wild type mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: